Detalles de la búsqueda
1.
Admission criteria in critically ill COVID-19 patients: a physiology-based approach.
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21257382
2.
Reduced mortality and shorten ICU stay in SARS-COV-2 pneumonia: a low PEEP strategy
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20089318
3.
Clonal dissection of immunodominance and cross-reactivity of the CD4+ T cell response to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436642
4.
Excessive inflammatory and metabolic responses to acute SARS-CoV-2 infection are associated with a distinct gut microbiota composition
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-465865
5.
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-437925
6.
ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-486377
7.
Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21249840
8.
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-509852
9.
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-493121
10.
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-515932
11.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-472269
12.
The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-355842
Resultados
1 -
12
de 12
1
Próxima >
>>